[P26-4-1] Comparison of reduced function CYP2D6 alleles on venlafaxine and risperidone metabolic ratios

Tore Haslemo¹, Robert Lovsletten Smith², Erik Eliasson³, Espen Molden⁴ (1.Diakonhjemmet Hospital, 2.Diakonhjemmet Hospital, 3.Karolinska University Hospital Huddinge, 4.Diakonhjemmet Hospital, University of Oslo)

[P26-4-2] Clinical evaluation of lithium with tubular reabsorption mechanisms and urinary pH based on hospital pharmacometrics

Daichi Yamaguchi¹, Yasuhiro Tsuji², Miki Sonoda³, Kenji Shin⁴, Hiroko Kito⁵, Yoichi Hiraki⁶, Hidefumi Kasai⁷, Hideto To⁸, Hidetoshi Kamimura⁹ (1.University of Toyama, 2.University of Toyama, 3.Yahata Kousei Hospital, 4.Iizuka Hospital, 5.Fukuma Hospital, 6.Beppu Medical Center, 7.Certara G. K., 8.University of Toyama, 9.Fukuoka University Hospital)

[P26-4-3] The estimation of pharmacokinetic parameters of lithium in children by pharmacokinetic modeling: a pilot study at Yuwaprasart Waithayopathum Child Psychiatric Hospital

Karunrat Tewthanom¹, Karunrat Tewthanom², Theerarat Tankhum³ (1.Silpakorn University, 2.Yuwaprasart Waithayopathum Child Psychiatric Hospital, 3.Yuwaprasart Waithayopathum Child Psychiatric Hospital)

[P26-4-4] Should older patients have lower serum lithium therapeutic ranges?

Lei Fu¹, Mary Kersey², Suzanne Waldman³, Tammie Taylor⁴, Meng Sun⁵, Kenneth Shulman⁶, David E.C. Cole⁷ (1.Sunnybrook Health Sciences Centre and University of Toronto, 2.Sunnybrook Health Sciences Centre, 3.Sunnybrook Health Sciences Centre, 4.Sunnybrook Health Sciences Centre, 5.Sunnybrook Health Sciences Centre and University of Toronto, 6.Sunnybrook Health Sciences Centre and University of Toronto, 7.Sunnybrook Health Sciences Centre and University of Toronto)

[P26-4-5] Neonatal abstinence syndrome after in utero exposure to antidepressant and benzodiazepines

Mariadelfina Molinaro¹, Georgios Eleftheriou², Simona De Gregori³, Michela Montagna⁴, Monica Broglia⁵, Marcello Di Tuccio⁶ (1.Fondazione IRCCS Policlinico San Matteo, 2.Papa Giovanni XXIII Hospital, 3.Fondazione IRCCS Policlinico San Matteo, 4.Fondazione IRCCS Policlinico San Matteo, 5.Fondazione IRCCS Policlinico San Matteo, 6.Fondazione IRCCS Policlinico San Matteo)

講演取消

[P26-4-6] Withdrawn

[P26-4-7] Efficacy of Levetiracetam and necessary of serum drug concentration measuring in epilepsy therapy: a preliminary study

Denpong Patanasethanont¹, Supinya Tuntapakul², Somsak Tiamkao³ (1.Khon Kaen University, 2.Khon Kaen University, 3.Khon Kaen University)

[P26-4-8] Safety and pharmacokinetics of 2-iminobiotin in neonates with therapeutic hypothermia after perinatal asphyxia

Laurent Favie¹, Cacha Peeters-Scholte², Huibert Tjabbes³, Paul Leufkens⁴, Antoine Egberts⁵, Frank van Bel⁶, Karin Rademaker⁷, Floris Groenendaal⁸ (1.University Medical Center Utrecht, 2.Neurophyxia BV’s Hertogenbosch, 3.Neurophyxia BV’s Hertogenbosch, 4.Neurophyxia BV’s Hertogenbosch, 5.University Medical Centre Utrecht, 6.University Medical Centre Utrecht, 7.University Medical Centre Utrecht, 8.University Medical Centre Utrecht)

[P26-4-9] A pharmacodynamic model of midazolam-induced sedation in terminally ill adult patients

Birgit C. P. Koch¹, Linda G. Franken², Anniek D. Masman³, Monique van Dijk⁴, Frans P.M. Baar⁵, Dick Tibboel⁶, Teun van Gelder⁷, Ron A.A. Mathot⁸, Brenda C.M. de Winter⁹ (1.Erasmus MC, 2.Erasmus MC, 3.Palliative Care Centre, Laurens Cadenza, 4.Erasmus MC - Sophia Children's Hospital, 5.Palliative Care Centre, Laurens Cadenza, 6.Erasmus MC - Sophia Children's Hospital, 7.Erasmus MC, 8.Academic Medical Centre, 9.Erasmus MC)

セッション情報

[P26-4] P26-4: Central nervous system drugs (3)